BR112023001489A2 - Formulação de ativador de plasminogênio tecidual - Google Patents

Formulação de ativador de plasminogênio tecidual

Info

Publication number
BR112023001489A2
BR112023001489A2 BR112023001489A BR112023001489A BR112023001489A2 BR 112023001489 A2 BR112023001489 A2 BR 112023001489A2 BR 112023001489 A BR112023001489 A BR 112023001489A BR 112023001489 A BR112023001489 A BR 112023001489A BR 112023001489 A2 BR112023001489 A2 BR 112023001489A2
Authority
BR
Brazil
Prior art keywords
plasminogen activator
tissue plasminogen
activator formulation
formulation
tissue
Prior art date
Application number
BR112023001489A
Other languages
English (en)
Inventor
Anthony Mina Anover Ray
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of BR112023001489A2 publication Critical patent/BR112023001489A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORMULAÇÃO DE ATIVADOR DE PLASMINOGÊNIO TECIDUAL. A presente invenção refere-se a formulações estáveis de ativador de plasminogênio tipo tecido (tPA). Em particular, a descrição refere-se a formulações específicas, métodos de prepará-las e métodos de usá-las.
BR112023001489A 2020-08-10 2021-08-06 Formulação de ativador de plasminogênio tecidual BR112023001489A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063063770P 2020-08-10 2020-08-10
PCT/EP2021/071977 WO2022033969A1 (en) 2020-08-10 2021-08-06 Tissue plasminogen activator formulation

Publications (1)

Publication Number Publication Date
BR112023001489A2 true BR112023001489A2 (pt) 2023-03-14

Family

ID=77520708

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023001489A BR112023001489A2 (pt) 2020-08-10 2021-08-06 Formulação de ativador de plasminogênio tecidual

Country Status (10)

Country Link
US (1) US20230310717A1 (pt)
EP (1) EP4192537A1 (pt)
JP (1) JP2023537106A (pt)
KR (1) KR20230047124A (pt)
CN (1) CN116033931A (pt)
AU (1) AU2021325324A1 (pt)
BR (1) BR112023001489A2 (pt)
CA (1) CA3185927A1 (pt)
MX (1) MX2023001085A (pt)
WO (1) WO2022033969A1 (pt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405426A1 (de) * 1994-02-21 1995-08-24 Boehringer Mannheim Gmbh Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate
WO2016007562A1 (en) * 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Methods and compositions for improving hemostasis

Also Published As

Publication number Publication date
AU2021325324A1 (en) 2023-02-23
JP2023537106A (ja) 2023-08-30
CA3185927A1 (en) 2022-02-17
US20230310717A1 (en) 2023-10-05
MX2023001085A (es) 2023-03-01
KR20230047124A (ko) 2023-04-06
WO2022033969A1 (en) 2022-02-17
EP4192537A1 (en) 2023-06-14
CN116033931A (zh) 2023-04-28

Similar Documents

Publication Publication Date Title
CO2019014682A2 (es) Composiciones y métodos para enzimas de internalización
ECSP20025070A (es) Proteínas trispecificas y métodos de uso
BR112018008684A2 (pt) formulações de toxina botulínica injetáveis e processos de uso das mesmas com longa duração do efeito terapêutico ou cosmético
CO2021006362A2 (es) Construcciones de ácido nucleico y métodos de uso
DOP2016000042A (es) Anticuerpos contra el inhibidor del activador de plasminógeno tipo 1 (pai-1) y usos de los mismos
BR122020001787A8 (pt) Conjugado de anticorpo-agente ativo, seus métodos de preparação, sua composição e seu uso
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
IN2015MU00865A (pt)
MX352823B (es) Formulaciones de proteinas que contienen aminoacidos.
MX2018012556A (es) Composiciones y metodos para programar celulas terapeuticas utilizando nanoportadores de acidos nucleicos dirigidos.
BR112016004095A2 (pt) administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores
AR099719A1 (es) Variantes de hppd y métodos de uso
MX2022014161A (es) Vacunas contra sars-cov-2.
CO2020004407A2 (es) Formulaciones de espora de nutriente y usos de las mismas
BR112019017393A2 (pt) formulações de evolocumab de baixa viscosidade, alta concentração e métodos para produzir as mesmas
CO2022000266A2 (es) Inhibidores de enzimas
WO2022047054A3 (en) Inhibitors of sars cov-2 infection and uses thereof
MX2021007839A (es) Composiciones para el cuidado oral.
MX2015017555A (es) Metodos y composiciones para aumentar la movilizacion de las celulas madre.
BR112018069079A2 (pt) construtos de alfavírus vivos atenuados e métodos e usos dos mesmos
CO2022003742A2 (es) Conjugados de interleuquina 10 y sus usos
BR112023001489A2 (pt) Formulação de ativador de plasminogênio tecidual
BR112019024750A2 (pt) uso de glutamina sintetase no tratamento da hiperamonemia
AR115051A1 (es) Enzimas quinureninasa humanas y sus usos
EA201591755A1 (ru) Композиции для лечения ксеростомии и для лечения зубов